TNS Feature Report and Next Gen Tech and Biotech That Could Change Our Lives
New York, NY -- March
17, 2022 -- InvestorsHub NewsWire -- via Traders News Source, a
leading independent equity research and corporate access firm
focused on small cap growth companies issues new
research.
Northwest
Biotherapeutics, Inc. (OTCQB:
NWBO) a biotechnology company developing DCVax®
personalized immune therapies for solid tumor cancers, after
spending years in preparation, is now operating under the UK
Medicines and Healthcare Products Regulatory Agency (MHRA) license
for manufacture of GMP (clinical grade) cell therapy products. The
company is in production of its first dendritic cell cancer
vaccine. The company developing electro-optic polymers to transmit
data at higher speeds with less power, Lightwave Logic,
Inc. (NASDAQ:
LWLG) has received a new U.S. patent on an invention
that will simplify modulator integration for high-volume foundry
manufacturing operations while enhancing polymer reliability to
enable a more effective photonic engine. U.S. Patent number
11,262,605 illustrates the design of a monolithic photonic
integrated circuit (PIC) that utilizes very high speed, low power
proprietary polymer modulators that will enable much faster data
rates for data communications, telecommunications, and data rich
environments.
Where will this new
license take NWBO in product development and what exactly did LWLG
just get patented? READ
MORE Copy and paste to browser may be required
- https://tradersnewssource.com/tns-feature-report-and-next-gen-tech-and-biotech-that-could-change-our-lives/
TNS Feature NFT and
Metaverse Report
Emerging electric
vehicle manufacturer, Mullen Automotive, Inc. (NASDAQ:
MULN) announced an update on their next-generation
solid-state polymer battery technology, which is a significant
advancement over today’s current lithium-Ion batteries. Data
collected from solid-state cell testing shows impressive results,
including a range of 600-plus miles on a full charge and over 300
miles of range delivered in 18 minutes with DC fast charging.
TPT Global Tech, Inc. (OTCQB:
TPTW) has announced that it intends to partner with
the City of Tuskegee Alabama to locate and invest in the
development, management, and operation of a "Smart City". The City
of Tuskegee is offering the Joint Partnership land, as needed, and
proposes to support the financing of the project through Municipal
Bonds. Completion of the project, estimated to be in three years,
should add to the State's GDP while bringing jobs directly and
indirectly to the region and creating a self-sustaining
ecosystem.
Does the new battery
tech at MULN signal the end of lithium-ion batteries and what will
the TPTW smart city look like? READ
MORE Copy and paste to browser may be required
- https://tradersnewssource.com/tns-feature-report-and-next-gen-tech-and-biotech-that-could-change-our-lives/
TNS Feature NFT and
Metaverse Report
Disclosure
Traders News Source
LLC (TNS) produces regular sponsored and non-sponsored reports,
articles, stock market blogs, and popular investment newsletters
covering small and micro-cap equity markets. TNS has two distinct
and independent departments. One department produces non-sponsored
analyst certified content generally in the form of press releases,
articles and reports covering equities listed on NYSE, NASDAQ, and
OTC exchanges. The other produces sponsored content (in most cases
not reviewed by a registered analyst), which typically consists of
compensated investment newsletters, articles and reports covering
listed stocks and micro-caps. Such sponsored content is outside the
scope of procedures detailed below.
TNS LLC has not been
compensated; directly or indirectly; for producing or publishing
this document.
PRESS RELEASE
PROCEDURES
The non-sponsored
content contained herein has been prepared by a writer (the
"Author") and is fact checked and reviewed by a third-party
research service company (the "Reviewer") represented by a
chartered financial analyst, for further information on analyst
credentials, please email editor@tradersnewssource.com. TNS LLC
provides necessary guidance in preparing the document templates.
The Reviewer has reviewed and revised the content, as necessary,
based on publicly available information which is believed to be
reliable. Content is researched, written, and reviewed on a
reasonable-effort basis. The Reviewer has not performed any
independent investigations or forensic audits to validate the
information herein. The Reviewer has only independently reviewed
the information provided by the Author per the procedures outlined
by TNS. TNS is not entitled to veto or interfere in the application
of such procedures by the third-party research service company to
the articles, documents, or reports. Unless otherwise noted, any
content outside of this document has no association with the Author
or the Reviewer in any way.
NO
WARRANTY
TNS, the Author, and
the Reviewer are not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake, or shortcoming. No liability is accepted whatsoever for
any direct, indirect, or consequential loss arising from the use of
this document. TNS, the Author, and the Reviewer expressly disclaim
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Additionally, TNS, the Author, and
the Reviewer do not (1) guarantee the accuracy, timeliness,
completeness, or correct sequencing of the information, or (2)
warrant any results from use of the information. The included
information is subject to change without
notice.
NOT AN
OFFERING
This document is not
intended as an offering, recommendation, or a solicitation of an
offer to buy or sell the securities mentioned or discussed and is
to be used for informational purposes only. Please read all
associated disclosures and disclaimers in full before investing.
Neither TNS nor any party affiliated with us is a registered
investment adviser or broker-dealer with any agency or in any
jurisdiction whatsoever. To download our report(s), read our
disclosures, or for more information, visit http://www.tradersnewssource.com.
For any questions,
inquiries, or comments reach out to us directly. If you're a
company we are covering and wish to no longer be featured on our
coverage list, contact us via email at: editor@tradersnewssource.com
CFA® and Chartered
Financial Analyst® are registered trademarks owned by CFA
Institute.
CONTACT: editor@tradersnewssource.com
SOURCE: Traders News
Source
Northwest Biotherapeutics (QB) (USOTC:NWBO)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Northwest Biotherapeutics (QB) (USOTC:NWBO)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024